Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.amiorganics.com | |
Market Cap | 4,394.49 Cr. | |
Enterprise Value(EV) | 4,339.42 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 22.86 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 52.71 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 31.86 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 163.01 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 7.39 | Calculated using Price: 1,204.85 |
Dividend Yield | 0.25 | Period Ending 2022-03 |
No. of Shares Subscribed | 3.64 Cr. | 36,437,062 Shares |
FaceValue | 10 | |
About AMI Organics Ltd. | ||
The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals. |
1 Day |
|
-2.21% |
1 Week |
|
+2.18% |
1 Month |
|
+13.47% |
3 Month |
|
+32.57% |
6 Month |
|
+20.38% |
1 Year |
|
+40.64% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
7 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 46.43 | 36.44 | 39.03 | 33.73 | 28.31 | 39.63 | 21.28 | |
Return on Capital Employed (%) | 35.54 | 35.91 | 38.24 | 33.80 | 26.25 | 33.01 | 24.05 | |
Return on Assets (%) | 13.87 | 12.04 | 13.99 | 12.64 | 12.34 | 16.74 | 13.42 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 27 | 39 | 58 | 82 | 112 | 167 | 522 | 594 | |
Non Curr. Liab. | 15 | 15 | 33 | 25 | 25 | 80 | 7 | 10 | |
Curr. Liab. | 49 | 55 | 65 | 106 | 95 | 166 | 129 | 163 | |
Minority Int. | |||||||||
Equity & Liab. | 91 | 109 | 155 | 213 | 232 | 413 | 659 | 767 | |
Non Curr. Assets | 25 | 42 | 66 | 89 | 111 | 191 | 223 | 297 | |
Curr. Assets | 66 | 66 | 87 | 124 | 121 | 216 | 429 | 470 | |
Misc. Exp. not W/O | 0 | 0 | 2 | 6 | 7 | ||||
Total Assets | 91 | 109 | 155 | 213 | 232 | 413 | 659 | 767 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 154 | 160 | 188 | 239 | 240 | 341 | 520 | 617 | |
Other Income | 3 | 0 | 3 | 0 | 3 | 1 | 3 | 4 | |
Total Income | 157 | 160 | 191 | 239 | 242 | 342 | 523 | 621 | |
Total Expenditure | -136 | -137 | -158 | -196 | -199 | -260 | -415 | -494 | |
PBIDT | 21 | 23 | 33 | 42 | 44 | 82 | 108 | 127 | |
Interest | -3 | -3 | -3 | -5 | -6 | -6 | -6 | -2 | |
Depreciation | -1 | -1 | -2 | -3 | -4 | -4 | -10 | -12 | |
Taxation | -5 | -7 | -10 | -12 | -7 | -18 | -20 | -29 | |
Exceptional Items | |||||||||
PAT | 13 | 12 | 19 | 23 | 27 | 54 | 72 | 83 | |
Minority Interest | |||||||||
Share Associate | |||||||||
Other Related Items | |||||||||
Consolidated Net Profit | 13 | 12 | 19 | 23 | 27 | 54 | 72 | 83 | |
Adjusted EPS | 84 | 80 | 123 | 22 | 26 | 6 | 20 | 23 |
Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 10 | 29 | 8 | 15 | 27 | 28 | -9 | |
Cash Fr. Inv. | -14 | -19 | -25 | -21 | -24 | -101 | -124 | |
Cash Fr. Finan. | 4 | -7 | 15 | 6 | 0 | 72 | 140 | |
Net Change | 0 | 3 | -2 | 0 | 3 | -1 | 8 | |
Cash & Cash Eqvt | 0 | 3 | 1 | 0 | 4 | 3 | 10 |
Mon, 29 May 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome The officials of Company held an Institutional Investors/Analysts meet as per the details attached |
Sat, 20 May 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome The officials of Company held an Institutional Investor/Analyst meet on May 19 2023 as per the details attached. |
Fri, 19 May 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript We hereby enclose the transcript of the Earnings conference call held on May 15 2023 post announcement of financial results for the fourth quarter & year ended March 31 2023 |
Mon, 29 May 2023 |
|
|
|
|
|